Compare Adaptive Biotechnologies Corp (ADPT) vs First Citizens BancShares Inc (FCNCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs First Citizens BancShares Inc — how do they compare? Adaptive Biotechnologies Corp trades at $24.45 (market cap $4.02B), while First Citizens BancShares Inc trades at $2,270.44 (market cap $25.26B). The key difference: First Citizens BancShares Inc is far larger — about 6.3× Adaptive Biotechnologies Corp's market cap, and First Citizens BancShares Inc pays a 0.37% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | FCNCA | |
|---|---|---|
Market Cap | $4.02B | $25.26B |
Sector | Health | Sector/Thematic |
52-Week High | $25.45 | $2.27K |
52-Week Low | $12.30 | $1.64K |
Enterprise Value | $4.08B | — |
Dividend Yield | — | 0.37% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →
